Snapshot from Aug 14, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Alkermes Q2 2026 Earnings Release
Business earnings release

Alkermes Q2 2026 Earnings Release

Analysis based on 6 articles · First reported Jul 14, 2026 · Last updated Jul 28, 2026

Sentiment
0
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The earnings release provides updated financial performance for Alkermes, potentially influencing investor sentiment. The market reaction will depend on the reported figures and forward guidance.

biopharmaceutical
Event Summary

Alkermes plc reported its financial results for the second quarter of 2026, ending June 30, 2026. The company hosted a conference call and webcast on July 28, 2026 to discuss the results and provide an update. Alkermes is a global biopharmaceutical company focused on neuroscience, with commercial products for alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, and narcolepsy. Its pipeline includes late-stage candidates for narcolepsy and idiopathic hypersomnia, and early-stage orexin 2 receptor agonists for ADHD and fatigue in multiple sclerosis and Parkinson's disease. The company is headquartered in Republic of Ireland with operations in United States — Massachusetts State Police and United States — Ohio.

Key Actions
50 Alkermes reported financial results
Entities Involved
stock
Alkermes
Alkermes reported its Q2 2026 financial results and hosted a conference call. The event is central to the company's quarterly reporting cycle.
Importance 100.0 Sentiment 0.0
exch
Nasdaq
Alkermes is listed on Nasdaq under ticker ALKS. The earnings release may affect its stock price on this exchange.
Importance 10.0 Sentiment 0.0
cnt
Republic of Ireland
Alkermes is headquartered in Republic of Ireland, but the event has no direct impact on the country.
Importance 5.0 Sentiment 0.0
govactor
United States — Massachusetts State Police
Alkermes has a corporate office and R&D center in United States — Massachusetts State Police, but the event has no direct impact on the state.
Importance 5.0 Sentiment 0.0
loc
United States — Ohio
Alkermes has a manufacturing facility in United States — Ohio, but the event has no direct impact on the state.
Importance 5.0 Sentiment 0.0
per
Sandy Coombs
Sandy Coombs is an investor contact for Alkermes, mentioned in the press release.
Importance 1.0 Sentiment 0.0
per
Katie Joyce
Katie Joyce is a media contact for Alkermes, mentioned in the press release.
Importance 1.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.